Paper Review Records
All Paper Review Records
10 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
57
days
Efficacy and safety of magnesium glycinate as add on therapy in hypomagnesemic asthma and chronic obstructive pulmonary disease patients: A randomised controlled study assessing inflammatory biomarkers
AuthorsManeesh Kumar Maddirevula; Muhasaparur G. Rajanandh; Boman Wesley
AffiliationsDepartment of Pharmacy Practice, SRM College of Pharmacy, Faculty of Medicine and Health Sciences, SRM Institute of Science and Technology, Kattankulathur, Chengalapattu, Tamil Nadu, 603203, India; Department of Pharmacy Practice, Mahathi College of Pharmacy, Madanapalle, Andhra Pradesh, 517319, India; Department of Pulmonary Medicine, Arogyavarm Medical Center, Madanapalle, Andhra Pradesh, 517319, India
113
days
m6A reader IGF2BP2 mediates airway remodeling by stabilizing Dixdc1 in asthma pathogenesis
AuthorsXiao-Mang Li; Bi-Wen Mo; Yan Gao; Yun-Xiang Chen; Bo Xiao; Yue Gu; Miao-Miao Liang; Hui-Min Li
AffiliationsGuilin Medical University, Guilin, 541004, Guangxi, China; Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Guilin Medical University, Guilin, 541001, Guangxi, China; Respiratory Disease Laboratory, The First Affiliated Hospital of Guilin Medical University, Guilin, 541004, Guangxi, China
135
days
Real-life application of the optical beta-adrenergic sweat test for people with cystic fibrosis
AuthorsKarina Kleinfelder; Anca Manuela Hristodor; Giorgio Centin; Antonella Casiraghi; Paola Minghetti; Emily Pintani; Marina Bertini; Claudio Sorio; Paola Melotti
AffiliationsDepartment of Medicine, Division of General Pathology, Cystic Fibrosis Laboratory “D. Lissandrini”, University of Verona, Verona, 37134, Italy; Cystic Fibrosis Centre, Azienda Ospedaliera Universitaria Integrata Verona, Verona, 37126, Italy; Department of Pharmaceutical Sciences, Università degli Studi di Milano, via G. Colombo 71, Milan, 20133, Italy
47
days
Effects of anumigilimab, an anti–G-CSF receptor mAb, after segmental LPS challenge: A Phase 1b trial in healthy volunteers
AuthorsJens M. Hohlfeld; Meike Müller; Philipp Badorrek; Laurent B. Nicolas; Oliver Vit; William G. Darby; Judith Field; Michael Larbig
AffiliationsDivision of Airway Research, Fraunhofer Institute for Toxicology and Experimental Medicine (ITEM), Nikolai-Fuchs-Str. 1, Hannover, 30625, Germany; Department of Respiratory Medicine and Infectious Disease, Hannover Medical School, Carl-Neuberg-Str. 1, Hannover, 30625, Germany; Member of the German Center for Lung Research (DZL), BREATH, Hannover Medical School, Carl-Neuberg-Str. 1, Hannover, 30625, Germany; Clinical Pharmacology and Pharmacometrics, CSL Behring AG, Wankdorfstrasse 10, Bern, 3014, Switzerland; Clinical Development, CSL Behring AG, Wankdorfstrasse 10, Bern, 3014, Switzerland; CSL Innovation, 30 Flemington, Parkville, 3010, Australia
106
days
PD05, a novel neutrophil elastase inhibitor, mitigates LPS-induced acute lung injury in a preclinical model
AuthorsSabita Singh; Ashish Jaiswal; Joytri Dutta; Archita Ray; Sayantan Sengupta; Sudip Dey; Arun Bandyopadhyay; Parasuraman Jaisankar; Ulaganathan Mabalirajan
AffiliationsMolecular Pathobiology of Respiratory Diseases, Cell Biology and Physiology Division, Council of Scientific and Industrial Research (CSIR)-Indian Institute of Chemical Biology (IICB), Kolkata, West Bengal, 700091, India; Cardiovascular Disease & Respiratory Disorders Laboratory, Department of Cell Biology & Physiology, CSIR-Indian Institute of Chemical Biology, Kolkata, India; Organic and Medicinal Chemistry Division, Council of Scientific and Industrial Research (CSIR)-Indian Institute of Chemical Biology (IICB), Kolkata, West Bengal, 700091, India; Gujarat Biotechnology University, India
213
days
Synergistic induction of apoptosis in lung cancer cells via TOP2A targeting through combined dihydroartemisinin and chrysin treatment
AuthorsHaidi Sun; Li Han; Hongwei Wu; Hongsheng Xue; Ming-Fei Lang; Jingyu Tan
AffiliationsThe First Affiliated Hospital of Jinzhou Medical University, Jinzhou, Liaoning, 121012, China; Medical College, Dalian University, Dalian, Liaoning, 116622, China; Affiliated Zhongshan Hospital of Dalian University, Dalian, Liaoning, 116001, China; School of Software Engineering, Dalian University, Dalian, Liaoning, 116622, China
94
days
Evodiamine protects against lung ischemia–reperfusion injury by attenuating SYK-associated TLR4/NLRP3 inflammasome activation and ferroptosis-related injury signatures
AuthorsWei Peng; Baiping Ge; Rui Zhang; Yunen Liu; Changci Tong; Chenguang Dong
AffiliationsDepartment of Pulmonary and Critical Care Medicine, The People's Hospital of Liaoning Province, Liaoning, 110016, China; Department of Emergency, The People's Hospital of Liaoning Province, Liaoning, 110016, China; Department of Pulmonary and Critical Care Medicine, Liaoning Fangda General Hospital, Liaoning, 110172, China; Shenyang Medical College, No. 146, Huanghe North Street, Shenyang, Liaoning, 110034, China
252
days
Evaluation of the effect of modulator therapies on medication complexity in adult cystic fibrosis patients
AuthorsEsen Deniz Akman Ar; Nadir Yalçın; Uğur Balaban; Oğuz Karcıoğlu; Ebru Damadoğlu; Ali Fuat Kalyoncu; Kutay Demirkan
AffiliationsDepartment of Clinical Pharmacy, Faculty of Pharmacy, Hacettepe University, Ankara, Türkiye; Department of Pulmonary Medicine, Faculty of Medicine, Hacettepe University, Ankara, Türkiye
219
days
Nicotinamide N-oxide alleviates sepsis-induced acute lung injury by inhibiting ferroptosis through activation of the SIRT1/AKT signalling pathway
AuthorsShujuan Liu; Mian Fu; Xiguang Liu; Yichen Jin; Liwen Fan; Qingyan Ni; Zihan Xu; Yusa Li; Jiawen Zhou; Huizhen Chen
AffiliationsInstitute of Neuroscience, Department of Neurosurgery, The Affiliated Lianyungang Hospital of Xuzhou Medical University, Lianyungang Clinical College of Nanjing Medical University, The First People's Hospital of Lianyungang, Lianyungang, 22000, China; Jiangsu Marine Pharmaceutical Resources Development Engineering Research Center, Jiangsu Key Laboratory of Marine Pharmaceutical Compound Screening, College of Pharmacy, Jiangsu Ocean University, Lianyungang, 222005, China
351
days
Pulmonary safety of Staccato alprazolam in healthy participants and participants with mild asthma: Phase 1, randomized, double-blind, placebo-controlled trial
AuthorsS. David Miller; Craig F. LaForce; Laura Barlow; Shikiko Watanabe; Aliceson King; Maria Burian; Hugues Chanteux
AffiliationsNortheast Medical Research Associates, North Dartmouth, MA, USA; North Carolina Clinical Research, Raleigh, NC, USA; Veramed, Twickenham, UK; UCB, Braine-l'Alleud, Belgium; UCB, Smyrna, GA, USA
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review96.4 days
Median77 days